T. Rowe Price Associates’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $990K | Buy |
87,893
+13,613
| +18% | +$153K | ﹤0.01% | 1986 |
|
|
2025
Q1 | $424K | Sell |
74,280
-8,535
| -10% | -$48.7K | ﹤0.01% | 2318 |
|
|
2024
Q4 | $814K | Buy |
82,815
+3,152
| +4% | +$31K | ﹤0.01% | 2053 |
|
|
2024
Q3 | $651K | Buy |
79,663
+4,718
| +6% | +$38.6K | ﹤0.01% | 2149 |
|
|
2024
Q2 | $991K | Sell |
74,945
-7,511
| -9% | -$99.3K | ﹤0.01% | 1897 |
|
|
2024
Q1 | $3.83M | Sell |
82,456
-4,222
| -5% | -$196K | ﹤0.01% | 1301 |
|
|
2023
Q4 | $5.86M | Buy |
86,678
+500
| +0.6% | +$33.8K | ﹤0.01% | 1174 |
|
|
2023
Q3 | $6.24M | Buy |
86,178
+305
| +0.4% | +$22.1K | ﹤0.01% | 1139 |
|
|
2023
Q2 | $6.39M | Sell |
85,873
-1,349
| -2% | -$100K | ﹤0.01% | 1146 |
|
|
2023
Q1 | $4.64M | Sell |
87,222
-14,249
| -14% | -$758K | ﹤0.01% | 1203 |
|
|
2022
Q4 | $6.86M | Sell |
101,471
-3,927
| -4% | -$265K | ﹤0.01% | 1118 |
|
|
2022
Q3 | $13.2M | Buy |
105,398
+657
| +0.6% | +$82K | ﹤0.01% | 1014 |
|
|
2022
Q2 | $9.97M | Sell |
104,741
-116,038
| -53% | -$11M | ﹤0.01% | 1316 |
|
|
2022
Q1 | $35.6M | Buy |
220,779
+164,045
| +289% | +$26.4M | ﹤0.01% | 1078 |
|
|
2021
Q4 | $18.9M | Buy |
56,734
+49,436
| +677% | +$16.4M | ﹤0.01% | 1299 |
|
|
2021
Q3 | $3.38M | Buy |
+7,298
| New | +$3.38M | ﹤0.01% | 1573 |
|